Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3    source : Ir.kalvista.com    save search
KalVista Pharmaceuticals Announces Initiation of KVD900 Phase 3 KONFIDENT Clinical Trial
Published: 2022-03-07 (Crawled : 12:00) - ir.kalvista.com
KALV | $11.65 -1.94% -1.8% 4 twitter stocktwits trandingview |
Health Technology
 | | O: -2.65% H: 0.0% C: 0.0%
kvd900 als trial phase 3
Gainers vs Losers
57% 43%

Top 10 Gainers
SINT | $0.0373 62.88% 65.82% 100M twitter stocktwits trandingview |
Health Technology
INVO | $1.82 139.47% 49.67% 1.4M twitter stocktwits trandingview |
Health Technology
HOLO | $2.24 -5.49% 27.74% 7.7M twitter stocktwits trandingview |

CTM | $0.2201 -2.31% 22.67% 48K twitter stocktwits trandingview |
n/a
SMFL | $0.485 19.37% 21.18% 2.4M twitter stocktwits trandingview |
Manufacturing
RCAT | $1.42 26.79% 20.0% 510K twitter stocktwits trandingview |
Information
SECO | $0.3659 -2.06% 18.82% 1.3M twitter stocktwits trandingview |
Retail Trade
VIAO | $0.262 0.77% 16.03% 14M twitter stocktwits trandingview |
Electronic Technology
SBOW | $30.01 -5.75% 14.93% 43 twitter stocktwits trandingview |
Energy Minerals
RYDE | $3.75 37.36% 14.67% 7.3K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.